Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psychosocial Distress Screening in Patients Treated for Head and Neck Cancer : The Value of Screening in Speech-Language Therapy Practice

NCT07851818 is registered in ClinicalTrials.gov with Hôpital NOVO as lead sponsor.

NCT NCT07851818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07851818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psychosocial Distress Screening in Patients Treated for Head and Neck Cancer : The Value of Screening in Speech-Language Therapy Practice
Lead sponsor
Hôpital NOVO
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
January 30, 2028
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer (h&n)